Terms: = Lung cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Clinical Outcome
5 results:
1. EGFR Exon 20 Insertion Mutations Display Sensitivity to hsp90 Inhibition in Preclinical Models and lung Adenocarcinomas.
Jorge SE; Lucena-Araujo AR; Yasuda H; Piotrowska Z; Oxnard GR; Rangachari D; Huberman MS; Sequist LV; Kobayashi SS; Costa DB
Clin Cancer Res; 2018 Dec; 24(24):6548-6555. PubMed ID: 30154228
[TBL] [Abstract] [Full Text] [Related]
2. Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
Su T; Liao J; Dai Z; Xu L; Chen S; Wang Y; Peng Z; Zhang Q; Peng S; Kuang M
Oncogene; 2018 Jun; 37(26):3514-3527. PubMed ID: 29559743
[TBL] [Abstract] [Full Text] [Related]
3. The targeted inhibition of hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract] [Full Text] [Related]
4. Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance.
Chen Z; Akbay E; Mikse O; Tupper T; Cheng K; Wang Y; Tan X; Altabef A; Woo SA; Chen L; Reibel JB; Janne PA; Sharpless NE; Engelman JA; Shapiro GI; Kung AL; Wong KK
Clin Cancer Res; 2014 Mar; 20(5):1204-1211. PubMed ID: 24327273
[TBL] [Abstract] [Full Text] [Related]
5. Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1α.
Schilling D; Bayer C; Li W; Molls M; Vaupel P; Multhoff G
PLoS One; 2012; 7(2):e31110. PubMed ID: 22347438
[TBL] [Abstract] [Full Text] [Related]
